Literature DB >> 33132782

The Integrated Treatment for Chronic Pain and Anxiety in a Patient with Breast Implant Illness Symptoms: A Case Report.

Asmita Patel1, Kathryn Blackmore2, Robyn Carruthers2.   

Abstract

INTRODUCTION: Women with breast implants may experience breast implant illness (BII). BII is comprised of a collection of systemic symptoms, such as fatigue and pain, that are postulated to be related to having breast implants. CASE
PRESENTATION: This case report documents the naturopathic treatment of a 35-year-old female patient diagnosed with fibromyalgia, tension headaches, and chronic anxiety, perceived to be linked to and exacerbated by her textured cohesive gel implants. The patient sought naturopathic treatment for support during the explant process of her breast implants.Naturopathic treatment was provided over a 3-month period in conjunction with prescribed medication for her anxiety and tension headaches.
CONCLUSION: At 3 months post-naturopathic treatment, the patient experienced a reduction in anxiety, fatigue, and self-reported pain. The integration of alternative therapies with prescribed pharmaceutical treatment appeared to positively impact the health of this patient.
Copyright © 2020 InnoVision Professional Media Inc.

Entities:  

Year:  2020        PMID: 33132782      PMCID: PMC7572138     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  22 in total

1.  A randomized, double-blind placebo-controlled trial of a Bach Flower Remedy.

Authors:  N C Armstrong; E Ernst
Journal:  Complement Ther Nurs Midwifery       Date:  2001-11

Review 2.  Bach flower remedies: a systematic review of randomised clinical trials.

Authors:  Edzard Ernst
Journal:  Swiss Med Wkly       Date:  2010-08-24       Impact factor: 2.193

3.  Systemic inflammatory reaction after silicone breast implant.

Authors:  Maira M Silva; Miguel Modolin; Joel Faintuch; Camila M Yamaguchi; Cintia B Zandona; Wilson Cintra; Haroldo Fujiwara; Rui Curi; Rolf Gemperli; Marcos C Ferreira
Journal:  Aesthetic Plast Surg       Date:  2011-03-18       Impact factor: 2.326

4.  Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica.

Authors:  Jintanaporn Wattanathorn; Lugkana Mator; Supaporn Muchimapura; Terdthai Tongun; Orapin Pasuriwong; Nawanant Piyawatkul; Kwanchanok Yimtae; Bungorn Sripanidkulchai; Jintana Singkhoraard
Journal:  J Ethnopharmacol       Date:  2007-12-04       Impact factor: 4.360

Review 5.  An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera).

Authors:  Morgan A Pratte; Kaushal B Nanavati; Virginia Young; Christopher P Morley
Journal:  J Altern Complement Med       Date:  2014-12       Impact factor: 2.579

Review 6.  The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.

Authors:  Edzard Ernst
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

7.  C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

Authors:  James D Chalmers; Aran Singanayagam; Adam T Hill
Journal:  Am J Med       Date:  2008-03       Impact factor: 4.965

8.  Traumeel - an emerging option to nonsteroidal anti-inflammatory drugs in the management of acute musculoskeletal injuries.

Authors:  Christian Schneider
Journal:  Int J Gen Med       Date:  2011-03-25

9.  Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974.

Authors:  Kieran Cooley; Orest Szczurko; Dan Perri; Edward J Mills; Bob Bernhardt; Qi Zhou; Dugald Seely
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

10.  Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.

Authors:  J Sarris; S Moylan; D A Camfield; M P Pase; D Mischoulon; M Berk; F N Jacka; I Schweitzer
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.